Stay updated on Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial
Sign up to get notified when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.
Latest updates to the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page
- Check5 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check41 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference2%
- Check56 days agoChange DetectedA new publication detailing the safety and efficacy of Vicriviroc (MK-7690) in combination with Pembrolizumab for colorectal cancer has been added, while previous participant group and treatment details have been removed.SummaryDifference6%
- Check63 days agoChange DetectedSeveral key health and clinical trial resources have been removed, including links to Dailymed, MSD documentation, and various government health websites.SummaryDifference0.3%
- Check70 days agoChange DetectedThe website has been updated to version v2.12.2, adding new resources and data fields for clinical trials, while the previous version v2.12.1 has been removed.SummaryDifference4%
Stay in the know with updates to Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.